Indian Ceftazidime Exporters: Complete Supplier Ranking with Market Share — 228 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ceftazidime supplier from India?

ZEISS PHARMACEUTICALS PRIVATE LIMITED is the largest ceftazidime exporter from India with a 19.5% market share and export value of $2.1M.

Q: How many ceftazidime suppliers are there in India?

There are 228 active ceftazidime exporters in India, collectively shipping $10.7M worth of ceftazidime across 920 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ceftazidime suppliers from India?

The top 5 ceftazidime suppliers from India — ZEISS PHARMACEUTICALS PRIVATE LIMITED, ANANTA MEDICARE LIMITED, VENUS REMEDIES LIMITED, THEON PHARMACEUTICALS LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — together control 46.4% of total ceftazidime export value from India.

Suresh Sormare

Ceftazidime

India Pharmaceutical Trade Intelligence

$10.7M228 Suppliers99 CountriesHS 30042019

ExportsIndia → GHANA19.5%India → UKRAINE14.3%

ImportsITALY → India$52.7M BELGIUM → India$327.7K

Ceftazidime Suppliers from India (2026) — 228 Exporters, $10.7M Market | TransData Nexus | TransData Nexus

Who Exports Ceftazidime from India — 228 Suppliers Behind a $10.7M Market

India's ceftazidime export market is supplied by 228 active exporters who collectively shipped $10.7M across 920 shipments. ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with a 19.5% market share, followed by ANANTA MEDICARE LIMITED and VENUS REMEDIES LIMITED. The top 5 suppliers together control 46.4% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Ceftazidime Suppliers & Exporters — 228 manufacturers, $10.7M export market, top destinations and formulations — Ceftazidime supplier data — 228 exporters · $10.7M market · 920 shipmentsTransData Nexus · Indian Customs Data

Top Ceftazidime Exporters from India — Ranked by Export Value

ZEISS PHARMACEUTICALS PRIVATE LIMITED is the leading ceftazidime exporter from India, holding a 19.5% share of the $10.7M market across 920 shipments from 228 exporters. The top 5 suppliers — ZEISS PHARMACEUTICALS PRIVATE LIMITED, ANANTA MEDICARE LIMITED, VENUS REMEDIES LIMITED, THEON PHARMACEUTICALS LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — collectively control 46.4% of total export value, indicating a competitive market. Individual shares are: ZEISS PHARMACEUTICALS PRIVATE LIMITED (19.5%), ANANTA MEDICARE LIMITED (14.9%), VENUS REMEDIES LIMITED (6.8%), THEON PHARMACEUTICALS LIMITED (3.2%), SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI (2.1%).

Top Ceftazidime Exporters from India

Ranked by export value · 228 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Ceftazidime Exporters from India — Ranked by Export Value. 228 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Ceftazidime exporters

Certification and compliance status for top Ceftazidime suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
STRIDES PHARMA SCIENCE LIMITED	Warning Letter, January 2	Yes, as of 2019	Yes	Not specified	Received FDA warning letter in January 2019; holds WHO-GMP and EU GMP certificat
IND SWIFT LIMITED	Warning Letter, 2011	Yes, as of 2011	Yes	Not specified	Received FDA warning letter in 2011; holds WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 2 leading Ceftazidime exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Ceftazidime sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical sector is characterized by a robust infrastructure and a skilled workforce, making it a pivotal hub for API manufacturing. While specific data on Ceftazidime production in Hyderabad is not readily available, the city's capacity for large-scale API synthesis suggests a significant role in its production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region hosts numerous manufacturing units specializing in the production of finished dosage forms. Companies such as SiNi Pharma, based in Ahmedabad, are involved in the manufacturing and export of Ceftazidime injections, indicating the region's active participation in the formulation and distribution of this antibiotic.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for Indian pharmaceuticals. Mumbai, being a major port city, facilitates the international distribution of pharmaceutical products. Cipla Limited, headquartered in Mumbai, is a notable player in the pharmaceutical industry, contributing to the export of various drugs. While specific figures for Ceftazidime exports from this region are not specified, the presence of such companies underscores the area's significance in global pharmaceutical trade.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Ceftazidime exporters from India

January 2026

Regulatory Approval

Venus Remedies Limited — Venus Remedies secures first generic Ceftazidime + Avibactam approval in Indonesia

Venus Remedies received marketing authorization from Indonesian regulators for its antibiotic combination, Ceftazidime + Avibactam, marking its first anti-infective approval in Indonesia. - IMPACT: This approval is expected to enhance Venus Remedies' export capabilities for Ceftazidime-based products in Southeast Asia.

Impact: This approval is expected to enhance Venus Remedies' export capabilities for Ceftazidime-based products in Southeast Asia.

March 2025

Regulatory Approval

Scott-Edil Advance Research Laboratories & Education Limited — Scott-Edil obtains approval for Ceftriaxone in Mozambique

Scott-Edil Advance Research Laboratories & Education Limited received authorization for its Ceftriaxone 1g product in Mozambique, expanding its market presence in Africa. (anarme.gov.mz) - IMPACT: This approval may lead to increased exports of Ceftazidime and related antibiotics to African markets.

Impact: This approval may lead to increased exports of Ceftazidime and related antibiotics to African markets.

Common Questions — Ceftazidime Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which ceftazidime supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with 8 recorded shipments worth $2.1M. ANANTA MEDICARE LIMITED (21 shipments) and VENUS REMEDIES LIMITED (73 shipments) are also established high-volume exporters.

Q How many ceftazidime manufacturers are there in India?

India has 228 active ceftazidime exporters with a combined export market of $10.7M across 920 shipments to 99 countries. The top 5 suppliers hold 46.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for ceftazidime from India?

Average FOB unit price: $17.38 per unit, ranging from $0.00 to $510.00. Average shipment value: $11.6K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ceftazidime

Ceftazidime

Who Exports Ceftazidime from India — 228 Suppliers Behind a $10.7M Market

Top Ceftazidime Exporters from India — Ranked by Export Value

Top Ceftazidime Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Venus Remedies Limited — Venus Remedies secures first generic Ceftazidime + Avibactam approval in Indonesia

Scott-Edil Advance Research Laboratories & Education Limited — Scott-Edil obtains approval for Ceftriaxone in Mozambique

Common Questions — Ceftazidime Suppliers from India

Q Which ceftazidime supplier from India is the most reliable for bulk orders?

Q How many ceftazidime manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for ceftazidime from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Theon Pharmaceuticals Limited — Theon Pharmaceuticals secures approval for Ceftriaxone in Mozambique

Analysis Methodology